The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice

Diana M Rommelfanger, Marta C Grau, Rosa M Diaz, Elizabeth Ilett, Luis Alvarez-Vallina, Jill M Thompson, Timothy J Kottke, Alan Melcher and Richard G Vile

Molecular Therapy (2013) 21: 348–357; doi:10.1038/mt.2012.204

The second author's name appeared incorrectly. The name should have been listed as Marta Compte.